Pars planitis: clinical features and class II HLA associations (Q33541979)

27 July 2017

Pars planitis: clinical features and class II HLA associations (English)

1 reference

27 July 2017

1 reference

Raja SC

1

1 reference

27 July 2017

Jabs DA

2

1 reference

27 July 2017

Dunn JP

3

1 reference

27 July 2017

Fekrat S

4

1 reference

27 July 2017

Machan CH

5

1 reference

27 July 2017

Marsh MJ

6

1 reference

27 July 2017

Bressler NM

7

1 reference

27 July 2017

1 March 1999

1 reference

27 July 2017

1 reference

27 July 2017

106

1 reference

27 July 2017

3

1 reference

27 July 2017

594-599

1 reference

Peripheral posterior segment inflammation, vitreous opacities, and edema of the posterior pole

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

Clinical and immunopathological studies of pars planitis in a family

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

The Association of HLA-B8, B51, DR2, and Multiple Sclerosis in Pars Planitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

Peripheral Uveitis in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

Uveitis, perivenous sheathing and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

Uveitis in association with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

Multiple sclerosis and the HLA-D region: linkage and association studies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

The association of HLA-DR15 and intermediate uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

Clinical diagnosis of multiple sclerosis. The impact of magnetic resonance imaging and ancillary testing. Rochester-Toronto Magnetic Resonance Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

The incidence of uveitis in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

Long-term visual outcome and complications associated with pars planitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

Association of HLA-DRw2 antigen with presumed ocular histoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

HLA-B7 and HLA-DR2 Antigens and Acute Posterior Multifocal Placoid Pigment Epitheliopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

HLA markers and prediction of clinical course and outcome in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

Giant cell arteritis: validity and reliability of various diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

DR2/DQw1 inheritance and haplotype sharing in affected siblings from multiple sclerosis families

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

HLA typing in acute optic neuritis. Relation to multiple sclerosis and magnetic resonance imaging findings

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990122-7

7 January 2021

10.1016/S0161-6420(99)90122-7

Identifiers

DOI

1 reference

27 July 2017

1 reference